In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

The effectiveness and outcomes of an educational program to decrease ribavirin and antimicrobial prescribing rates and associated costs for patients with respiratory syncytial virus (RSV) lower ...

Community pharmacies play a pivotal role in educating older adults about RSV, as 78% lacked prior education from healthcare providers. The study found that 63% of participants chose to receive the ...

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

Experts make new recommendations on RSV and meningitis vaccines, but it’s unclear what happens next It’s not clear who will decide whether to accept those recommendations.

As new viruses like COVID-19, bird flu, norovirus, and RSV (respiratory syncytial virus) continue to spread, ... There are also other organizations promoting antiviral education,” he advised.

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

Of the more than 500 women surveyed, 3 out of 4 (75.6%) had never heard of RSV. However, nearly half (48.5%) said they were willing to get the RSV vaccine. The primary reason participants said ...

Educational intervention programs are tools for improving the quality, safety, effectiveness, and cost-benefit of patient care. The overriding principles are to provide physicians with accurate ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following the advice of a recently fired panel of government vaccine advisers.